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QSAR MODELING OF CHEMICAL PENETRATION ENHANCERS USING
NOVEL REPLACEMENT ALGORITHMS
by
Hui Qiu
The applications of transdermal delivery are limited because of the resistance of the skin
to drug diffusion. Only potent drugs, with molecular weight less than 500 Da, are suitable
to cross the skin barrier. Chemical Penetration Enhancers (CPEs) are used to promote the
absorption of solutes across the dermal layers. In this investigation, a Quantitative
Structure-Activity Relationship (QSAR) model is applied to relate chemical penetration
enhancer structures with the flux enhancement ratio through a statistical approach.
A database, consisting of 61 non-polar CPEs, is selected for the study. Each
compound is represented by 777 QSAR descriptors, which encode the physical
characteristics of the CPE and its structure. Selection replacement techniques are used to
choose the eight most important descriptors. The enhancement ratio, an evaluation of the
effect of the CPE, correlates well with this subset of features. The QSAR model can be
adopted to predict factors that need to be adjusted to improve permeation of the drug
through the skin.
Three QSAR models are developed using different algorithms: forward stepwise
regression (FSR), replacement (RM) and enhanced replacement (ERM) techniques. The
first two methods yield equations with poor predictive power. The enhanced replacement
method gives the best results, which meet cross-validation criteria: q2 = 0.79, 0.63 and
0.76 for the training set, test set and combined data, respectively. These results meet the
predetermined criteria.
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CHAPTER 1
INTRODUCTION

1.1

Objective

Chemical penetration enhancers (CPEs) are useful because of their ability to overcome
skin barrier resistance and to stimulate drug transport across the skin. However, the task
of choosing CPEs, for a particular drug, can be challenging as it may involve expensive
and time-consuming trial-and-error experiments. The objective of this thesis is to build a
quantitative structure-activity relationship (QSAR) model from a set of skin penetration
enhancers. Mathematical expressions are derived that relate the Enhancement Ratio (ER),
a measure of the effectiveness of the CPEs, to the enhancers’ molecular descriptors.
Replacement methods are applied to select a subset of structural features. One of the
main advantages of the study is the creation of a platform to help connect the drug release
rate to a few QSAR molecular descriptors. This procedure can be conducted to screen the
best CPEs from a large database.

1.2

Background Information

Transdermal drug-delivery systems (TDDS) are developed to transport drugs through the
skin to the systemic circulation. The most common preparation is a medicated adhesive
patch that is placed on the skin to administer a specific dose of medication. Traditional
TDDS have a porous membrane covering a reservoir of medication embedded in an
adhesive. Figure 1.1 presents three different types of TDDS drug release mechanisms.

1
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After traversing the dermal layers, the molecules enter the bloodstream through the
capillary walls and reach an effective concentration at the target site.

a. Reservoir system.

Backing

Drug
Membrane

b. Matrix system without a rate-controlling membrane.

Adhesive
Liner
Drug-in-Adhesive

c. Matrix system with a rate-controlling membrane.

Figure 1.1

TDDS different drug release mechanism.
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TDDS can be used as local therapies or to produce systemic effects. It is
especially useful for chronic disease because the method is noninvasive, selfadministered and provides the patient with a controlled release of the medication.
Because the skin prevents the entry of foreign substances and guards against nutrient and
water loss, TDDS are also applied for topical skin disease.
Apart from these benefits, TDDS have unique advantages when compared with
other dosage forms. They can prevent metabolism of the active pharmaceutical ingredient
(API) and avoid first-pass effect of the liver when the medication is taken orally. Risks,
such as cross-infections through reuse of needles, posed by hypodermic injections are
averted. In addition, the patches are not painful and especially safe for low-income and
developing countries [1,2].
The first transdermal patch approved by the FDA as a prescription drug can be
traced back to December 1979. Scopolamine was the API used to treat motion sickness
[3-5]. Because of the slow delivery rate and the fact that only a small amount of the agent
can be delivered through the skin, side effects, such as dry mouth, dizziness and
hallucination, associated with potent scopolamine were decreased [6,7]. During the mid1980’s, a nicotine patch was studied and a patent issued. This new dosage form attracted
the public attention because of its efficacy in reducing craving for cigarettes [8-10].
Today, there are more than twenty different types of transdermal delivery systems, such
as nitroglycerin, estradiol and lidocaine, which are approved by the FDA [11]. The
research environment spurs the emergence of combination patches, containing multiple
drugs, iontophoretic and ultrasonic delivery systems [1].
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The transdermal route is only appropriate for a few drugs because of the presence
of the stratum corneum, mainly composed of dead cells. A rational selection is based on
key factors: physico-chemical properties of the drug (such as solubility, crystallinity,
molecular weight, polarity, melting point), pharmacokinetic parameters (such as half-life,
volume of distribution, total body clearance, therapeutic plasma concentration,
bioavailable factor) and biological factors (skin toxicity, site of application, allergic
reactions, skin metabolism, skin permeability) [12]. All available drugs formulated in a
patch have three fundamental characteristics, which allow them to cross the skin
effectively: low molecular mass (<500 Da), high lipophilicity (oil soluble) and small
required dose (up to milligrams) [13]. These properties are found in first-generation
delivery systems. The emergence of second-generation (e.g., devices with CPEs and
iontophoresis) and third-generation delivery systems (e.g., microneedles) make a
significant contribution to medicine [1]. Physical or chemical enhancement techniques
are very effective delivery systems that are used to overcome the resistance of the stratum
corneum. One of the popular methods is the use of CPEs. CPEs are chemical compounds
added to the formulation in TDDS to increase skin permeability [14].
In the past, less attention was paid to hydrophilic solutes in academic settings
because of the lipid bilayer structure of skin. The situation has changed with the
introduction of CPEs. More investigations on mathematical modeling of transdermal
transport of hydrophilic drugs are conducted [15,16]. Passive transport these solutes also
allow diffusion through the epidermis [13].
Penetration enhancers should be nontoxic, nonirritating, and deprived of any
pharmacological activity. In addition, compatibility among the CPEs, the drug and other
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materials present in the system is desirable. The skin can recover its barrier function
quickly after removal of the CPE. Although it is difficult to find a CPE with all the
desired properties, many compounds show most of these features.
CPEs are classified as terpenes, terpenoids and essential oils, pyrrolidones and
their derivatives (such as N-methyl-2-pyrrolidone), fatty acids and esters, sulfoxide and
similar compounds (e.g., dimethyl sulfoxide (DMSO), alcohols, glycols and glycerides,
(e.g., ethanol, propylene glycol); azones (e.g., laurocapram) and other miscellaneous
enhancers (such as phospholipids, lipid synthesis inhibitors, cyclodextrin complexes,
amino acid derivatives, cloﬁbric acid, dodecyl-N,N-dimethylamino acetate and enzymes)
[17]. Given a particular active pharmaceutical ingredient, it would be a massive project to
conduct experiments using compounds in each group to select the most effective CPE.
Therefore, modern computational techniques are applied to assist in the process and
suggest CPEs that can be tested in the laboratory.
Quantitative structure–activity relationships (QSAR) are empirical linear models
that have been widely used in the pharmaceutical, chemical sciences, environment
protection policy and health research. These models map a set of physico-chemical
properties or theoretical molecular descriptors of compounds (X) to a response variable
(Y) where Y represents a biological activity. Examples of response variables are the
molar concentration of a compound that inhibits 50% growth of bacteria (IC 50 ) [18], the
octanol-water partition coefficient [19] and the cytotoxic activity [20]. Therefore, QSAR
models are only one kind of regression models. In addition, such an approach can also be
used for classification purposes where the predictor variable is assigned a categorical
value. Regardless of the specific application of the QSAR model, the number of
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descriptors can be very large (i.e., 1000). As a result, it is important to choose particular
descriptors that best explain the response variable.
The goal of this project is to derive a QSAR model to relate structures of a set of
nonpolar CPEs to the flux enhancement ratio using hydrocortisone as a control.
Hydrocortisone, also known as Cortisol, is a steroid hormone. Its structure is
shown in Figure 1.2. The main glucocorticoid is secreted by the zona fasciculata of the
adrenal cortex [21]. It has multiple effects and is used to treat inflammation, allergy,
collagen diseases, asthma, adrenocortical deficiency, shock and some neoplastic
conditions [22]. The main function is to increase blood sugar, stimulate gluconeogenesis,
suppress the immune system and aid in fat, protein and carbohydrate metabolism [23].

Figure 1.2

2D structure of hydrocortisone.

Source: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5754 Retrieved on March 30, 2013.

Several dosage forms of hydrocortisone are ready for use: lotion, cream, gel,
ointment and enema. It is available both as an over-the-counter (low-strength, 0.5% or
1%) or prescription drug (high-strength). Ghafourian et al. investigated the enhancing
activities of terpenes towards hydrocortisone [24,25]. Simon et al. studied the influence
of 61 non-polar CPEs on the transdermal delivery rate of hydrocortisone [14].
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The descriptors are usually produced by software packages such as Molecular
Modeling Pro™ Plus (MMP+). Three different methods for deciding an optimal subset of
descriptors were studied by Simon and Abdelmalek [14]: the replacement method (RM),
the enhanced replacement method (ERM) and the traditional forward stepwise regression
(FSR). The hydrogen bond acceptor, polar surface area, moment of inertia, glass
transition temperature (T g ), molar volume, radius of gyration (RG), dipole moment and
polarity correlates well with the ER [14]. However, these eight properties were selected
from thirty-one descriptors previously used in CPE studies. The present study will use a
larger database to build the QSAR model. The applicability domain, which was not
determined in the previous study, will be defined.

CHAPTER 2
CHEMICAL PENETRATION ENHANCERS AND MOLECULAR
DESCRIPTORS

2.1

Overview

Chemical penetration enhancers are widely used in dermal related products, such as
transdermal drug-delivery systems and cosmetics. Common CPEs are classified as
terpenes, terpenoids and essential oils; pyrrolidones and their derivatives; fatty acids and
esters; sulfoxide and similar compounds; alcohols, glycols and glycerides; azones and
other miscellaneous enhancers [17]. Each group has specific advantages and
disadvantages. For example, DMSO, a common chemical penetration enhancer, is a
sulfoxide. It increases penetration because of its interaction with the stratum corneum and
solubilization with the drug itself. However, DMSO might cause skin irritation, or may
be fatal to a human when exposed to high concentrations [26].
Azone, also named laurocapram, is a clear and colorless liquid that dissolves
poorly in water but mixes well with most organics. It affects the absorption of
hydrophilic drugs more significantly than lipophilic agents. Laurocapram has an effective
concentration in the range of 1-6%. Although the CPE’s action on the skin is slow, about
two to ten hours, its impact could last several days because azone accumulates gradually
in the stratum corneum [27].
Except for the amino-acid derivatives, most CPEs would provoke skin irritation
after traversing the epidemic cells. These derivatives are absorbed into the stratum
corneum lipid barrier, increase the mobility of the barrier lipids and improve drug
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permeation, as a result. Janůšová et al. studied the proline derivative L-Pro2 and found
that it could increase ER by up to 40% and yielded better results than azone. Contrary to
single-chain lipid-like substances, double-chain lipid-like compounds did not increase the
flux, as noted in [28].
A higher permeation can be achieved when different CPEs are combined [5].
Propylene glycol (PG) is a good example. When used alone, PG mildly improves the
transport of estradiol and 5-fluorouracil [29]. It exhibits a synergistic action when
combined with other CPEs, such as ethanol and oleic acid. Janůšová et. al found that a
mixture of proline derivative L-Pro2 and PG increased the theophylline ﬂux 40 times
higher than that of PG acting alone and 2.5 times greater than that of L-Pro2 in water [28].

2.2

Chemical Penetration Enhancers in This Study

Codes representing the molecular structures of the sixty-one CPEs used in the study are
listed in Appendix A.

2.3

Molecular Descriptors

Computational applications in chemoinformatics and toxicoinformatics are becoming
popular in drug research and discovery phases. Many predictive models are based on the
compound structure or activity. Since the structure alone cannot be represented by the
model, it is necessary to extract structural information and convert it into numerical or
digital representations. “The molecular descriptor is the final result of a logical and
mathematical procedure which transforms chemical information encoded within a
symbolic representation of a molecule into a useful number or the result of some
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standardized experiment” [30]. Therefore, molecular descriptors can be experimental or
theoretical. Examples of experimental measurements are log P, dipole moment, any
physico-chemical properties or biological activities. Theoretical descriptors are symbolic
representations of the molecules and can be further classified as:
•

Zero-dimensional (0D) descriptors, obtained from the chemical formula and
independent of the molecular structure (i.e. atom type counts, the molecular mass,
atomic charge)

•

1D-descriptors, which represent a list of structural fragments (i.e. list of structural
fragments, functional group count)

•

2D-descriptors, which are topological indices that are derived by converting
molecular structures into graphs (i.e. graph invariants)

•

3D-descriptors, calculated from a geometrical or 3D representation of a molecule
(i.e. 3D-MoRSE descriptors, WHIM descriptors, GETAWAY descriptors,
quantum-chemical descriptors, size, steric, surface and volume descriptors)

•

4D-descriptors, which come from a stereo-electronic or lattice representation (i.e.
those stemmed from GRID or CoMFA methods, Volsurf) [31,32].

Molecular descriptors help interpret properties of existing CPEs as well as guide
the design of new molecules. With the emergence of these new metrics, a descriptor may
fail to describe important characteristics of a compound while providing a wealth of
information on the structure of another molecule. Descriptors are instrumental in
assessing the importance of theoretically established models [30]. When they are the
result of an optimization strategy, these numbers are expected to correlate well with at
least one property and be sensitive to gradual change in molecular structures [33].
In this study, SMILES, a linear notation system is used. Such notations are twodimensional representation alternatives to the molecular graph [30].
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2.4

Screening of Molecular Descriptors

The software Molecular 2D Descriptors (Mold2) Generator Software, version 2 (center
for bioinformatics, NCTR, FDA, USA) is used to transform a CPE’s structure into 777
descriptors. Part of them listed in Appendix B. MATLAB® (The Mathworks Inc., MA,
USA) is later used. Only the eight most relevant descriptors, a number much less than the
supplied data, are selected to represent the CPEs. The output of the QSAR model is the
ER.

CHAPTER 3
ENHANCEMENT RATIO

3.1

Enhancement Ratio

Skin penetration enhancement techniques were developed to improve bioavailability and
increase the range of drugs that can be administered topically and transdermally [31]. An
enhancement ratio (ER) is usually calculated to give an accurate measure of the
effectiveness of the accelerant. This number is defined as the ratio of the flux in the
presence of a fixed concentration of the CPE to the delivery rate when the CPE is not
added to the formulation [14, 34]:
𝐷𝑒𝑙𝑖𝑣𝑒𝑟𝑦 𝑟𝑎𝑡𝑒 𝑎𝑓𝑡𝑒𝑟 𝑒𝑛ℎ𝑎𝑛𝑐𝑒𝑟 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡

Enhancement Ratio (ER)=𝐷𝑒𝑙𝑖𝑣𝑒𝑟𝑦 𝑟𝑎𝑡𝑒 𝑏𝑒𝑓𝑜𝑟𝑒 𝑒𝑛ℎ𝑎𝑛𝑐𝑒𝑟 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡
3.2

(3.1)

Enhancement Ratio Test Method

Two methods are available for the evaluation of skin permeation in vitro: the static and
flow-through cell experiments [35-37]. The static Franz diffusion cell test is widely used
for calculating ER values. This apparatus contains two compartments: a receptor cell (a
static receptor solution reservoir with a side-arm sampling port) and a donor cell [38]
(Figure 3.2). In flow-type Franz cells, the receptor medium is continuously circulated
through the receptor compartment.
In the original work, data were obtained using static Franz diffusion cells [38].
These systems are also recommended by the FDA [39]. CPEs were first applied to the
membranes for 24 hours and placed between the two compartments. Samples were
removed from the receptor cell and replaced with the same volume of fresh solution at
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pre-set time intervals. Drug concentration was determined by spectrophotometry and the
diffusion coefficient was estimated after applying to Higuchi equation [40,41]. The earlytime release data (less than 60%) can be modeled by the following equation [42]:
1�
2

𝑄
𝐷𝑡
= 2𝐶0 ∙ � �
𝐴
𝜋

(3.2)

where Q is the cumulative amount of drug collected in the receiver chamber (mg), A is
the area available for diffusion (cm2), D is the diffusion coefficient (cm2/h), C 0 is the
initial concentration (mg/cm3) and t is the time.

Figure 3.2

Scheme of the static Franz diffusion cell.

CHAPTER 4
DESIGN OF SKIN PENETRATION ENHANCERS USING REPLACEMENT
METHODS FOR THE SELECTION OF MOLECULAR DESCRIPTORS

In Section 1.2, three feature-selection methods in QSAR studies were briefly discussed:
RM, ERM and FSR. Another option is to implement these algorithms first to extract the
best descriptors. The second phase would consist of building nonlinear input-output
mappings, such as an artificial neural network (ANN), to represent the data [14].
Although this approach produced superior results, when compared to a traditional QSAR,
this study is mainly focused on the use of Mold2 with advanced replacement techniques
to produce linear relationships between descriptors and the ER.

4.1

Multiple Linear Regression

Multiple linear regressions are commonly used in QSAR studies to develop the
relationship between descriptors (independent variable) and the dependent variable
(biological activity). Patel et al. (2002) derived a correlation between skin permeability
and the compound’s hydrophobicity, molecular size and hydrogen bonding ability [43].
Mercader et al. (2010) credited changes in 50% inhibitory concentration (IC 50 ) to the
mean topological charge index of order 1, the average molecular weight, 3D – MoRSE –
signal 30 weighted by atomic masses and the first component symmetry directional
WHIM index weighted by atomic polarizabilities [44].
The generic form of a multiple linear regression model, given p observations, is:
𝑦 = 𝛼 + 𝛽1𝑋𝑖 + 𝛽2𝑋2 + ⋯ + 𝛽𝑝𝑋𝑝

14

(4.1)

15
where α is the intercept, Xi is a feature, also called a descriptor (e.g., hydrophobicity,
molecular weight) and β is the partial regression coefficient.

4.2

Replacement Method

Techniques, such as FSR and Genetic Algorithm (GA), can be used to conduct the multiparameter, non-linear inverse analysis [45]. The latter strategy is inspired by the process
of Darwinian evolution because the mechanism selects the fittest individuals over several
generations. Mercader et al. proposed the replacement method (RM) which yields
systems with better statistical parameters than the GA and the FSR. The GA replaces the
descriptors randomly and does not calculate the error in the regression coefficient as in
the case of RM. In addition, tuning of the mutation probability, crossover probability and
generation gap complicates the process [46].
The response (y) may be related to a host of molecular descriptors (X). The
challenge is to decide on a subset of relevant input variables d={X 1 , X 2 ,…, X p } from a
large pool of dimension N. An effective algorithm should be applicable to problems with
the size of d in the range of 0 to 10 and N > 1000. The RM procedure, based on the
minimum standard deviation (SD), can select a subset of the population. First, descriptors
are chosen randomly and replaced one at a time by the remaining elements. The set that
produces the smallest SD is kept. Second, the input variable with the coefficient showing
the largest relative deviation is replaced. The procedure continues until there is no need to
make additional substitutions. In the end, the best variables of the first path are obtained.
The process is repeated for all possible paths and the predictor variables with the smallest
SD are kept [46, 47].
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4.3

Enhanced Replacement Method

The enhanced replacement method (ERM), an improved version of RM, was developed
later by Mercader et al. It yields even better statistical parameters than the RM. The
technique is similar to that of the RM because it uses the minimum standard deviation for
identifying the descriptors [48]. The main difference is that the ERM combines two
algorithms in the sequence: RM and MRM (modified replacement method). The latter
technique is similar to the RM except that, in this case, the descriptor with the largest
error is replaced in each step regardless of the standard deviation value [46].

4.4

Stepwise Regression Method

Stepwise regression creates a mathematical representation by adding or removing
variables continuously until a subset based on the F-ratio statistic is selected. There are
three main approaches: forward selection, backward elimination and bidirectional
elimination. In the forward selection, variables are added to an “empty” model. The
regression terms, that are not used, are examined one by one to see whether they could
improve the model. The procedure continues until further improvement is no longer
viable. Backward elimination starts from all candidate predictors and removes the input
variable with the smallest F-ratio [49,50]. Bidirectional elimination is a combination of
the above two schemes.

4.5

Classification of Training and Testing Data

QSARs make it possible to interpret molecular properties and/or to predict other
unknown compounds. Ideally, the tool should be able to predict chemical properties or
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biological activities of those compounds that are not included in the model development
[51]. The most common method of achieving this goal is to divide compounds into
training and test samples. While the learning phase relies on the training data, validation
uses the test set. Selection of data belonging to these two categories is not arbitrary. The
training data should cover the whole descriptor space and the test set could be within the
range of (or close to) points in the training set. Therefore, the training examples should be
diverse and representative of the compounds studied.

4.6

Applicability Domain

QSAR modeling assumes that all compounds share similar properties and influence the
dependent variable using analogous mechanisms. The model is expected to perform well
on samples that are within a domain fixed by the training data. This “applicability domain”
(AD) is an important concept in building a QSAR and is based on the compound’s
characteristics or biological activities (e.g., physical, chemical and biological features).
The QSAR prediction cannot be considered reliable if the data falls outside of this
domain. Eriksson et al. introduced several techniques of defining AD to assess the
predictive power of the model [52]. In this study, the determination of leverage values
(the William’s plot) is adopted. Leverage h is a scale of the influence of each compound
on the formula. The leverage of a compound in the original variable space is defined as:
ℎ𝑖 = 𝑥𝑖 𝑇 (𝑋 𝑇 𝑋)−1 𝑥𝑖

(i=1,2,…n)

(4.2)

where x i is the feature vector of the considered compound and X is the descriptor matrix
constructed from the training set [53]. The warning leverage (h*) is defined as:
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ℎ∗ =

3𝑃
𝑛

(4.3)

where n is the number of training compounds, P is the number of explanatory variables
plus one [54].
William’s plot is the graph of standardized residual versus leverage values. Other
than the influence of a point, the plot can also show the Euclidean distances of all
compounds to the model through standardized residuals for both training and test data.
The plot can be analyzed as follows: If h is greater than h*, the compound has a
large influence on the model. If the cross-validated standardized residual is larger than
three standard deviations, the compound is outside of the range and is considered a
response outlier [54]. Therefore, h is less than h* for a point in the domain and the
standardized residual is within three standard deviations.

4.7

Evaluation of QSAR Results

It is important to have a method to validate QSARs. The leave-one-out (LOO) or leavesome-out (LSO) cross-validation procedures are the common assessment tools. In this
study, LSO is chosen. The coefficient of determination q2 is used to evaluate the accuracy
of the model, which is calculated according to the formula:
𝑞2 = 1 −

𝑆𝑆𝑒𝑟𝑟
𝑆𝑆𝑡𝑜𝑡

(4.4)

where SS err is the sum of squares of residuals and SS tot is the total sum of squares, which
is proportional to the sample variance:
2
𝑆𝑆𝑒𝑟𝑟 = �(𝑦𝑖 − 𝑦�)
𝚤

(4.5)
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with

𝑆𝑆𝑡𝑜𝑡 = �(𝑦𝑖 − 𝑦�)2
𝑛

(4.6)

(4.7)

1
𝑦� = � 𝑦𝑖
𝑛
𝑖=1

where 𝑦𝑖 , 𝑦�𝚤 and 𝑦� are the experimental, predicted and averaged activities, respectively.

According to Golbraihk et al., a QSAR is predictive if the following conditions

are satisfied for the test set [51]:
𝑅 2 > 0.6
𝑞 2 > 0.5

(4.8)
(4.9)
2

𝑅 2 − 𝑅0 2
𝑅 2 − 𝑅0′
<
0.1
𝑜𝑟
< 0.1
𝑅2
𝑅2

0.85 ≪ 𝑘 ≪ 1.15 𝑜𝑟 0.85 ≪ 𝑘 ′ ≪ 1.15

(4.10)

(4.11)

where R is the correlation coefficient between 𝑦�𝚤 and 𝑦𝑖 ; R 0 2 is the coefficient of

determination between 𝑦�𝚤 and 𝑦𝑖 .and R 0 ’2 is the coefficient of determination of 𝑦𝑖 versus

�𝚤 and 𝑦𝑖 and 𝑦𝑖 versus 𝑦�,
𝑦�;
𝚤 k and k’ are the slopes of the regression lines (i.e., between 𝑦
𝚤
respectively) through the origin.

CHAPTER 5
IMPLEMENTATION

In previous contributions, QSAR models were developed to predict the effects of sixtyone (61) nonpolar enhancers on the transdermal delivery of hydrocortisone [14, 55]. In
[14, 34], the software MOLECULAR MODELING PRO™ Plus (MMP+) was used to
calculate the CPEs. In [14], it estimated nearly 114 descriptors of the molecular structures.
However, this number was later reduced to 31 features commonly used in studies of skin
penetration enhancers. A linear model based on eight input variables could predict the ER
because of the pretreatment with the accelerants. R2 values of 0.683, 0.683 and 0.671,
corresponding to ERM, RM and FSR algorithms, respectively, were computed. In this
study, the QSAR was based on 777 variables calculated using the Mold2 software. This
large and diverse set of descriptors encodes 1D and 2D chemical structure information
[56].

5.1

Software and the Flow Diagram

The following tools are applied in this study:
•

Online SMILES Code Translator

•

PUBCHEM

•

Molecular 2D Descriptors (Mold2) Generator Software, version 2 (center for
bioinformatics, NCTR, FDA, USA)

•

CHEMBENCH

•

MATLAB® (The Mathworks Inc., MA, USA)
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Some of the websites relevant to this work are provided in [57–59]. A flow diagram,
describing how these tools are implemented in sequence, is given in Figure 5.1.

61 chemical penetration
enhancer names
PUBCHEM

SMILES code

SMILES code translation

Mold2

“.sdf” file is created.

save ER
values of 61
chemical
penetration
enhancers to
a “.act” file

“ouput.txt” is
created for
the molecular
descriptors.

save as “.X”
file

Figure 5.1

upload the files into
CHEMBENCH to
divide 61 chemical
penetration enhancers
into training and test
sets

Flow diagram of software.
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5.2

SMILES Code

Simplified Molecular Input Line Entry System (SMILES) (http://www.daylight.com,
2006; http://www.epa.gov, 2006) is a chemical language that helps explain the structure
of a compound. The system encodes information in a way that the molecular data can be
integrated for QSAR applications [60]. A SMILES string, though produced by a
canonicalization algorithm, is unique for each structure.
There are five basic syntax rules for SMILES:
1

atoms and bonds

2

simple chains

3

branches

4

rings

5

charged atoms
The U.S. Environmental Protection Agency provides more details on these five

rules on its website [61].

5.2.1

SMILES Code Acquisition

The PUBCHEM website [57] provides the SMILES code. Figure 5.2 is the screenshot of
a “PUBCHEM structure search." Once a compound name is entered, a search is launched
and a code is created.
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Figure 5.2

5.2.2

Screenshot of “PUBCHEM structure search”.

SMILES Code Translation

Given a specific compound, the following steps are carried out to translate SMILES
strings to an SDF file:
1

From the PUBCHEM website, enter the specific compound name to generate the
SMILES code.

2

From the online code translator [58], enter the string in “Input Format”.

3

Choose SDF, kekule and 2D, and click “Translate”.

4

The SDF file is shown after selecting the “Result” option.

For a batch of compounds, a TXT file containing the SMILES strings should be
created.
Figure 5.3 is the screenshot of “Online SMILES Translator”, where “A” is the
field to copy the string for the compound and “B” is the location for a batch of
compounds.
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Figure 5.3

Screenshot of “online SMILES translator”.

5.3

Molecular Descriptor

As discussed in Chapter 2, compound structures are difficult to interpret. For the QSAR
analysis, it is necessary to identify a series of predictors that describe the molecule in an
accurate and comprehensive way. 2D chemical structures for molecular descriptors are
presented in this study. Such representations are simpler and, sometimes lead to better
predictions than 3D designs [62-64]. Ceriums, Dragon, and Molconn-Z are common
options for forming 2D-based descriptors. However, Mold2 was selected in this work
because of the low computing cost. In addition, compared to the other tools, Mold2 is
applicable to smaller datasets and provides similar information [65]. The software is also
freely available to the public and can generate 777 descriptors.
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The procedure followed to produce the predictor variables consists of these steps:
1

Double-click “Mold2.bat”, then enter SDF file in “Input SDF file” to obtain an
output file and a report file.

2

The “descriptors.txt” is created and lists the descriptors in the output file, while
“report.txt” contains an error report.

5.4

Random Selection of Training and Testing Sets

The sixty-one data are randomly divided into training and testing set in order to validate
the QSAR created. The testing set consists of 20% of the data, i.e., 12 CPEs; the
remaining patterns were selected for training. A reliable QSAR model depends on the
quality of the data points in the training phase. It may be necessary to randomize the data
several times to make sure that the examples provided are representative of the total
population. A number of alternative techniques, such as the sphere exclusion method, are
implemented in the literature [51, 66]. In this work, the randomization step was repeated
several times.
This procedure was pursued in CHEMBECH:
1

The ACT, SDF and X files were uploaded at the “Modeling with Descriptor”
under the “Dataset” Tab.

2

The “continuous” option and the “standardized structures” boxes were selected.
At the “New Type” option, Mold2 was entered.

3

In “Random split”, “Use activity binning” was chosen and twenty percent was
entered for the set size.

4

The name of the dataset was added.

5

The result was shown in “My bench” Tab. A zip file, which contained the results,
was available in the Datasets section.
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5.5

MATLAB®

MATLAB®, developed by MATHWORKS, is widely accepted in industry and academia.
More than a million engineers and scientists use it for numerical computation,
visualization and programming. It allows users to manipulate a matrix, analyze and plot
functions and data, develop algorithms and create models. It can be further extended after
interfacing with programs, including C, C++, Java and Fortran [67].

5.5.1

Removal of Redundant “0” and Test Set from Data

A program was written in Matlab to remove unnecessary variables. Columns of zeroes
were deleted from the data.

5.5.2

Application of Replacement Method, Enhanced Replacement Method and
Forward Stepwise Regression

Three Matlab functions, “rmt.m”, “erm.m” and “stepwise.m”, written by Mercader et al.
[48], were applied to perform the RM, the ERM and the FSR, respectively. Eight features
were extracted using these techniques.

5.5.3

Calculation of the Regression Coefficients

A Matlab function, “ls.m” written by Mercader et al. (2007) [48], estimated the statistical
parameters of a model, including the regression coefficients for the eight descriptors. This
function yields the correlation coefficient (R), standard deviation (S), F-statistic, average
of the squared residuals, Akaike Information Criterion (AIC), a fit index (FIT) for the
model and the errors in the coefficients [48].

CHAPTER 6
RESULTS AND VALIDATION OF QSAR MODELS

SMILES codes for the 61 CPEs are listed in Appendix A. Part of the descriptors are
presented in Appendix B. The full database is provided in [65].

6.1

Selection Result of Training and Test Sets

The test set, randomly selected in CHEMBENCH, was determined by the lowest MAE
(mean absolute error) value (9.625) and was composed of the following 12 compounds:
enhancers 8, 11, 12, 17, 29, 30, 35, 37, 43, 45, 46 and 50. The remaining data formed the
training set (see Appendix A).

6.2

Applicability Domain Plot

Figure 6.1 shows the applicability domain (AD) of the model. The dots and triangles
represent the training and test sets, respectively. All points fall within three standard
deviation units while two dots are outside of the AD (i.e., greater than the warning
leverage h*). The CPEs are within the response range; there is no response outlier. Two
training samples have great influence on the model: compound 58 (leverage: 0.83069)
and compound 60 (leverage: 0.556). The test set is within the AD. Therefore, its
prediction is reliable.
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Figure 6.1

Applicability domain plot.

6.3

RM Result

Eight relevant descriptors are identified using the RM algorithm:
D712: number of group donor atoms for H-bonds (with N and O)
D223: average valence vertex connectivity order-5 Index
D498: Moran topological structure autocorrelation length-4 weighted by atomic
Sanderson electronegativities
D139: topological distance count order-3
D361: ratio of convention bonds with total path counts
D563: lowest eigenvalue from Burden matrix weighted by polarizabilities order-8
D468: Geary topological structure autocorrelation length-6 weighted by atomic
Sanderson electronegativities
D144: mean atomic van der Waals Carbon-scale
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The standard deviation of the resulting model is 8.9870. The enhancement ratio (ER)
equation can be written as:
Enhancement Ratio (ER) = -492.3785709 - 8.334892401 ×
(number of group donor atoms for H-bonds (with N and O)) 971.1163824 × (average valence vertex connectivity order-5
Index)

-

178.7675311

autocorrelation

×

length-4

(Moran

weighted

topological
by

atomic

structure
Sanderson

electronegativities) - 0.529379308 × (Topological distance count
order-3) - 39.18517223 × (ratio of convention bonds with total

(6.1)

path counts) - 78.08649465 × (Lowest eigenvalue from Burden
matrix weighted by polarizabilities order-8) + 83.89527801 ×
(Geary topological structure autocorrelation length-6 weighted
by atomic Sanderson electronegativities) + 1110.128698 × (mean
atomic van der Waals Carbon-scale)
The q2 value is 0.76.

6.4

ERM Result

Application of the ERM methodology yields the following descriptors:
D595: highest eigenvalue from Burden matrix weighted by polarizabilities order-8
D583: highest eigenvalue from Burden matrix weighted by electronegativities SandersonScale order-4
D148: mean atomic electronegativity Sanderson-scaled on Carbon
D719: number of group CH2RX”
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D487: Moran topological structure autocorrelation length-1 weighted by atomic van der
Waals volumes
D252: structure centric index
D202: vertex connectivity order-2 index
D146: mean atomic electronegativities Pauling-scaled on Carbon
The standard deviation is 8.2596. As a result, the ER equation is given by:
Enhancement Ratio (ER) = 3475.644081 - 32.3125901 × (Highest
eigenvalue from Burden matrix weighted by polarizabilities
order-8) + 135.7830714 × (Highest eigenvalue from Burden
matrix weighted by electronegativities Sanderson-Scale order-4)
+ 10260.89116 × (mean atomic electronegativity Sandersonscaled on Carbon) + 10.88119291 × (number of group CH2RX) +
80.43358564 × (Moran topological structure autocorrelation
length-1 weighted by atomic van der Waals volumes) +
1.3463313 × (structure centric index) - 8.755968019 × (vertex
connectivity order-2 index) - 14528.47706 × (mean atomic
electronegativities Pauling-scaled on Carbon)
The q2 value is 0.79.

6.5

FSR Result

The descriptors obtained after using the traditional FSR method are:
D252: structure centric index
D026: number of Oxygen
D563: lowest eigenvalue from Burden matrix weighted by polarizabilities order-8

(6.2)
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D253: structure lopping centric group index
D492: Moran topological structure autocorrelation length-6 weighted by atomic van der
Waals volumes
D621: number of group esters (aliphatic)
D494: Moran topological structure autocorrelation length-8 weighted by atomic van der
Waals volumes
D503: Moran topological structure autocorrelation length-1 weighted by atomic
polarizabilities
The standard deviation for the model is 9.4732. The ER equation becomes:
Enhancement Ratio (ER) = 18.57872893-3.67957 × (structure
centric index) + 13.39025 × (number of Oxygen) - 108.095 ×
(Lowest

eigenvalue

from

Burden

matrix

weighted

by

polarizabilities order-8) + 29.18622 × (structure lopping centric
group index) - 94.0105 × (Moran topological structure
autocorrelation length-6 weighted by atomic van der Waals
volumes) - 24.3658 × (number of group esters (aliphatic)) +
25.98054 × (Moran topological structure autocorrelation length8 weighted by atomic van der Waals volumes) - 11.544 × (Moran
topological structure autocorrelation length-1 weighted by
atomic polarizabilities)
The q2 value is 0.73.

(6.3)
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6.6
6.6.1

Validation of Test Set Result

Validation of the RM Result

Using the results from the RM algorithm, the following statistics are obtained for the
testing set: ȳ = 14.4267, SS tot = 3563.0367, SS err = 4288.7209, q2 = -0.2037. Table 6.1
lists the test set and the corresponding descriptors.

6.6.2

Validation of the ERM Result

The following statistics are achieved for the test set using the ERM results: ȳ = 14.4267,
SS tot = 3563.0367, SS err = 1331.6290, q2 = 0.6263. Table 6.2 lists the test set and the
corresponding descriptors.

6.6.3

Validation of the FSR Result

Application of the Forward step wise method gives: ȳ = 14.4267, SS tot = 3563.0367, SS err
= 3796.6429, q2 = -0.0656. Table 6.3 lists the test set data and the corresponding
descriptors.

Table 6.1 Predicted ER Values for the Test Set. The RM Algorithm was Applied
D712

D223

D498

D139

D361

D563

D468

D144

Experimental

Predicted

compound8

0

0.067

0.461

24

1.186

-0.025

0.947

0.589

25.78

36.23288

compound11

0

0.058

0.559

23

1.2

-0.025

0.797

0.592

12.67

18.18059

compound12

0

0.061

0.531

24

1.193

-0.025

0.816

0.591

36.44

20.50153

compound17

0

0.068

0.459

31

1.165

-0.025

0.786

0.587

1.96

17.00913

compound29

0

0.065

0.565

22

1.216

-0.023

0.915

0.591

8.6

18.84592

compound30

0

0.066

0.49

19

1.233

-0.023

0.899

0.593

12.8

33.0823

compound35

1

0.06

0.359

34

1.056

-0.016

1

0.589

5

56.47404

compound37

0

0.087

0.255

18

1.13

-0.025

0.948

0.578

60.1

46.87978

compound43

0

0.073

0.282

13

1

0.601

0.9

0.575

2.17

7.150154

compound45

0

0.069

0.403

12

1

0.599

0.839

0.576

1.03

-13.9182

compound46

0

0.076

0.334

14

1

0.599

0.887

0.575

2.4

-6.52295

compound50

0

0.073

0.285

18

1

0.599

0.915

0.574

4.17

4.271429

D stands for descriptor; the number represents the number of the descriptor. For example, D712 is the descriptor 712, “number
of group donor atoms for H-bonds (with N and O)”.
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Table 6.2 Predicted ER Values for the Test Set. The ERM Algorithm was Applied
D595

D583

D148

D719

D487

D252

D202

D146

Experimental Predicted

compound8

2.126

4.322

0.962

3

0.221

20

9.04

0.953

25.78

17.33268

compound11

1.922

4.232

0.968

3

0.256

16

7.98

0.957

12.67

21.86659

compound12

1.96

4.26

0.966

3

0.243

17

8.333

0.955

36.44

30.18565

compound17

2.229

4.323

0.959

3

0.202

20

9.748

0.95

1.96

19.21556

compound29

1.74

4.138

0.96

1

0.152

14

7.166

0.951

8.6

-5.62518

compound30

1.617

4.135

0.962

1

0.161

14

6.813

0.952

12.8

7.749986

compound35

2.28

4.268

0.946

1

0.149

16

10.505

0.938

5

13.01073

compound37

1.642

4.138

0.947

2

0.16

15

6.992

0.94

60.1

38.35765

compound43

1.077

3.954

0.955

1

0.239

11

5.694

0.948

2.17

-1.05753

compound45

1.064

3.876

0.959

2

0.341

9

5.182

0.951

1.03

7.105402

compound46

1.224

3.876

0.955

2

0.296

11

5.889

0.948

2.4

-2.64006

compound50

1.517

4.028

0.951

1

0.247

14

7.237

0.944

4.17

3.015228
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Table 6.3 Predicted ER Values for the Test Set. The FSR Algorithm was Applied
D252

D026

D563

D253

D492

D621

D494

D503

Experimental Predicted

compound8

20

3

-0.025

3.821

0.348

1

0.391

1.636

25.78

33.57198

compound11

16

3

-0.025

3.347

0.554

1

0.489

1.803

12.67

15.70806

compound12

17

3

-0.025

3.446

0.519

1

0.451

1.744

36.44

17.90213

compound17

20

3

-0.025

3.616

0.505

1

0.345

1.54

1.96

12.74228

compound29

14

2

-0.023

3.13

0.385

0

0.455

1.948

8.6

40.82374

compound30

14

2

-0.023

3.243

0.419

0

0.503

2.019

12.8

41.35286

compound35

16

1

-0.016

2.972

0.188

0

0.21

0.91

5

38.84379

compound37

15

1

-0.025

3.354

0.228

0

0.27

1.592

60.1

44.57074

compound43

11

2

0.601

2.865

0.319

0

0.41

0.324

2.17

0.459715

compound45

9

2

0.599

2.562

0.444

0

0.828

0.377

1.03

-2.31167

compound46

11

2

0.599

2.865

0.346

0

0.445

0.324

2.4

-0.95306

compound50

14

2

0.599

3.243

0.28

0

0.336

0.269

4.17

3.04837
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CHAPTER 7
DISCUSSION

7.1

Model Analysis of the Replacement Methods

The RM, ERM and FSR methods extracted different descriptors from the database and
resulted in distinct QSAR models.

7.1.1

The Replacement Method Algorithm

The q2 values for the RM-generated model are: 0.76 (for training data), -0.20 (for test
vector) and 0.55 (for all 61 CPEs). Based on Eqs 4.8 – 4.11, the following results are
calculated for the test data (Figure 7.1): R2 = 0.28, R 0 2 = 0.24,

𝑅 2 −𝑅0 2
𝑅2

= 0.17 and k = 0.59.

The prediction fails to meet the requirements specified in Section 4.7. The results for the
61 CPEs are shown in Figure 7.2.

7.1.2

The Enhanced Replacement Method Algorithm

The q2 values for the ERM-based model are: 0.79 (for training data), 0.63 (for test set)
and 0.76 (for the full dataset). Additional statistics are (Figure 7.3): R2 = 0.64, R 0 2 = 0.64,
𝑅 2 −𝑅0 2
𝑅2

= 4.36×10-3 and k = 1.11. The prediction meets the conditions outlined in Section

4.7. Figure 7.4 shows a correlation plot with the 61 CPEs.
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7.1.3

The Forward Stepwise Regression Algorithm

The q2 values calculated when the FSR algorithm is applied are: 0.73 (for training set), 0.066 (for test set) and 0.56 (for the 61 CPEs). Other test statistics are (Figure 7.5): R2 =
0.29, R 0 2 = 0.27,

𝑅 2 −𝑅0 2
𝑅2

= 0.064 and k = 0.63. The prediction is poor. The correlation

plot is shown for the 61 CPEs (Figure 7.6).
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Correlation between the experimental and predicted flux ratios for the full

dataset. The FSR algorithm was applied.

7.2

Evaluation of Models

The RM and FSR approaches yield negative q2 values. Based on Equation 4.4, the mean
of the data outperforms the QSAR models. Therefore, the predictor variables selected by
both methods cannot predict ER when a linear trend is assumed. The ERM algorithm
produces the best result, in accordance with previous observations. Simon and
Abdelmalek (2012) analyzed the same 61 non-polar CPEs by extracting eight different
descriptors using MMP+. Multiple linear regression models were also derived. After
applying the ERM technique, the q2 values were 0.683 and 0.74 for the full dataset and
training data, respectively. The q2 values for the 61 CPEs were 0.683 and 0.671 with the
RM and FSR algorithms, respectively. Those findings show that the ERM performed
more effectively when the test results were considered and could serve as a viable
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modeling tool for the selection for molecular structures [14]. This observation is
consistent with the three cases studied in this work. In addition, the ERM results in
Section 7.1.2 outperformed those recorded in [14]. The main reason is the application of
the public domain software Mold2 which can create more descriptors at a low
computational cost while conveying sufficient structural information. In summary, the
combination of ERM and Mold2 predictors is a promising approach for designing CPEs.

7.3

Interpretation of Eight Enhanced Replacement Method Descriptors

D595 and D583 belong to the burden eigenvalues, a subclass of eigenvalues-based
descriptors [30]. Polarizability, applied in D595, is a fundamental property and is defined
as the ability of particles to be polarized. It controls the dynamical response of a bound
system to an external field and can shed light on a molecule's internal structure [69]. As a
chemical property, electronegativity (in D583) is related to the tendency of an atom, or a
functional group, to pull electrons towards itself. Sanderson electronegativity’s model can
compute parameters, such as bond energies, molecular geometry and NMR spin-spin
constants [70].
D148 and D146 belong to electronegativity scales, a subclass of quantumchemical descriptors. The Sanderson scales χ s are based on covalent radii. Sanderson
group electronegativity (ESG) is calculated by the equation [30]:
𝐸𝑆𝐺𝑖 = (χ𝑆,1 , χ𝑆,2 , … , χ𝑆,𝑚 )1/𝑚

(7.1)

where χ s is the Sanderson electronegativity and m the number of atoms of the ith
molecular group.
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Pauling defined electronegativity as “the power of an atom in a molecule to attract
electrons to itself”. Pauling-scale χ PA is estimated using the ionization potential (IP) and
the electronic affinity of valence state (EA) [30]:
𝜒𝑃𝐴 = 0.303 ×

𝐼𝑃 + 𝐸𝐴
2

(7.2)

D719 belongs to the subclass of structural features while D487 is a Moran
topological structure autocorrelation descriptor, which is expressed as I d (w) with
d=1,2,..,10). The function I d (w) is defined as [30, 71]:
1 𝑁
∑𝑖=1 ∑𝑁
�)(𝑤𝑗 − 𝑤
�)
𝑗=1 𝛿𝑖𝑗 (𝑤𝑖 − 𝑤
∆
𝐼𝑑 (𝑤) =
1 𝑁
∑
�)2
𝑁 𝑖=1(𝑤𝑖 − 𝑤

(7.3)

where the weight w is any atomic property and 𝑤
� is its average value; N is the number of
atoms; d is the considered topological distance and 𝛿𝑖𝑗 is the Kronecker delta. The sum of

the Kronecker deltas is given by ∆ .

D252 is a centric index and is calculated using a partition of graph vertices based
on its position relative to the center. Details can be found in [30]. D202 is a connectivity
index that can be calculated from the vertex degree δ of the atoms in a molecular graph
where all the hydrogen atoms are excluded. The vertex degree represents the count of its
σ electrons in the plot and can be estimated by the following equation:
𝐴

1

𝛿𝑖 = � 𝑎𝑖𝑗 = 𝑓𝑖 =
𝑗=1

(7.5)

[𝐀2 ]

𝑖𝑖

where δ i stands for the vertex degree of the ith atom, a ij marks the ith row of the
adjacency matrix A and 1f i is the i th row of the distance matrix D [30].
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7.4

Correlation of the Enhanced Replacement Method-based Descriptors

A correlation study was conducted to detect possible relationships among ERM-based
properties (Table 7.1). If the correlation coefficient is greater than 0.8 (or less than -0.8),
the two variables are strongly correlated and the label “s” is used. Values between 0.3
and 0.8 (or -0.8 and -0.3) describe weak correlation and the symbol “w” is assigned. If
the value is smaller than 0.3 (or greater than -0.3), there is no correlation, a case that is
described by “n." Such analyses help to identify which variables can be omitted in future
modeling efforts.
Table 7.1 Correlation between the Eight Descriptors
D595
D595
D583
D148
D719
D487
D252
D202
D146

7.5

s
n
w
n
w
s
n

D583 D148
0.9067 0.1961
0.3578
w
w
w
n
w
w
w
s
w
w
s

D719
0.5775
0.6497
0.6827
w
w
w
w

D487
-0.2103
-0.2101
0.6708
0.4301
w
n
w

D252
0.3042
0.4372
0.5722
0.6652
0.4798
w
w

D202
0.9329
0.8954
0.3416
0.6560
-0.0436
0.4602

D146
0.1465
0.3183
0.9968
0.6712
0.6920
0.5752
0.2987

n

Application of the Enhanced Replacement Method Model

Although The ERM algorithm is effective at selecting the best CPEs, compounds to be
tested should be within the AD of the model (Figure 6.1). The leverage is expected to be
smaller than a warning value and the ER response not to exceed the three-standard
deviation threshold. This is especially important for the design of new CPEs for a certain
drug.
The sign of the regression coefficients of the QSAR is instructive for designing
CPEs. To increase the transdermal flux, variables with positive coefficients should have
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large values. An opposite effect is observed when the coefficient is negative. For the
ERM-based selections, D595, D202 and D146 need to be as small as possible while the
other five variables should take on large values. The magnitudes of coefficients can help
evaluate the contribution of each feature: the larger the coefficient absolute value, the
more dominant the variable. The influence level is expressed as:
D252 < D202 < D719 < D595 < D487 < D583 < D146 < D148

(7.1)

Reversible decoding (or inverse QSAR) is a process for re-constructing the
structure, or fragment, by using calculated molecular descriptors. Without performing
experiments, the response of a new molecule can be predicted using Equation 6.2. The
influence level is an important consideration in screening for the best CPEs. The difficult
task in reversible decoding is the ability to transform these descriptors into structures, a
step necessary for guiding the design or synthesis of new molecules. In fact, this could be
a limiting factor in choosing software that produces structural descriptors. Reversible
decoding is an important research area that deserves increased attention [72].

CHAPTER 8
CONCLUSIONS

In this study, three selection algorithms, RM, ERM and FSR, were applied to a database
composed of 61 nonpolar CPEs. Eight features, which affected the enhancement ratio the
most, were chosen from 777 molecular descriptors created by Mold2. QSAR models were
developed using hydrocortisone as a control. Although the RM and FSR method yielded
high q2 values during training (0.73 and 0.76, respectively), the test set results were
unsatisfactory.
The ERM produced the best QSAR model, with high predictive power. The q2
values were: 0.79 (training), 0.63 (testing) and 0.76 (full database). These statistics
suggest that the approach can be used to explain the relationship between ER and
molecular descriptors. Another potential application is in the area of reverse decoding to
promote the design of new CPEs. For the technique to be effective, the compound needs
to belong to the model’s AD.
This work focused on a method to fabricate CPEs that would improve the
permeation of hydrocortisone through the skin. A strategy that is also applicable to other
drugs. Research on CPEs to aid the transdermal transport of insulin is continuing in our
laboratory. The response variable is the permeability instead of the ER [73].
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APPENDIX A
SMILES CODES FOR THE SIXTY-ONE CPES

SMILES codes representing the molecular structures of the sixty-one CPEs are
listed.
compound1

C1CCCC(=O)N(CCCCCCCCCCCC)C1

compound2

C1CCC(=O)N1CC(=O)OCCCCCCCC

compound3

C1CCC(=O)N1CC(=O)OCCCCCCCCC

compound4

C1CCC(=O)N1CC(=O)OCCCCCCCCCC

compound5

C1CCC(=O)N1CC(=O)OCCCCCCCCCCC

compound6

C1CCC(=O)N1CC(=O)OCCCCCCCCCCCC

compound7

C1CCC(=O)N1CC(=O)OCCCCCCCCCCCCC

compound8

C1CCC(=O)N1CC(=O)OCCCCCCCCCCCCCC

compound9

C1CCC(=O)N(CC(=O)OCCCCCCCC)C1

compound10

C1CCC(=O)N(CC(=O)OCCCCCCCCC)C1

compound11

C1CCC(=O)N(CC(=O)OCCCCCCCCCC)C1

compound12

C1CCC(=O)N(CC(=O)OCCCCCCCCCCC)C1

compound13

C1CCC(=O)N(CC(=O)OCCCCCCCCCCCC)C1

compound14

C1CCC(=O)N(CC(=O)OCCCCCCCCCCCCC)C1

compound15

C1CCC(=O)N(CC(=O)OCCCCCCCCCCCCCC)C1

compound16

C1CCCC(=O)N(CC(=O)OCCCCCCCCCCCC)C1

compound17

C1CCCC(=O)N(CC(=O)OCCCCCCCCCCCCCC)C1

compound18

C1CCC(N2CCCC2=O)C(=O)N(CCCCCCCCCC)C1

compound19

C1CCC(N2CCCC2=O)C(=O)N(CCCCCCCCCCCC)C1

compound20

C1CCC(N2CCCC2=O)C(=O)N(CCCCCCCCCCCCCC)C1

compound21

C1CCC(N2CCCC2=O)C(=O)N(CCCCCCCCCCCCCCCC)C1

compound22

C1CCC(N2CCCC2=O)C(=O)N(CC(=O)OCCCCCC)C1
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compound23

C1CCC(N2CCCC2=O)C(=O)N(CC(=O)OCCCCCCCC)C1

compound24

C1CCC(N2CCCC2=O)C(=O)N(CC(=O)OCCCCCCCCCC)C1

compound25

compound27

C1CCC(N2CCCC2=O)C(=O)N(CC(=O)OCCCCCCCCCCCC)C
1
C1CCC(N2CCCC2=O)C(=O)N(CC(=O)OCCCCCCCCCCCCCC
)C1
C1CCN(C(CCCCCCCCCC)=O)CC1

compound28

C1CN(C(CCCCCCCCCC)=O)CC1

compound29

C1CC(=O)N(C(CCCCCCCCCC)=O)CC1

compound30

C1C(=O)N(C(CCCCCCCCCC)=O)CC1

compound31

C1CCC(=O)C(CCCCCCCCCC)C1

compound32

C1C(=O)C(CCCCCCCCCC)CC1

compound33

C1N(C(CCCCCCCCCC)=O)CCSC1

compound34

CC(N(CCCCCCCCCCCC)CCCCCCCCCCCC)=O

compound35

C1C(CC(C(=O)NCCCCCCCCCCCC)(C2)C3)CC2CC13

compound36

C1N(C(CCCCCCCCCCC)=O)CCOC1

compound37

C1C(=O)N(CCCCCCCCCCCCC)CC1

compound38

C1CCC(=O)N(CCCCCCCCCCCCC)C1

compound39

O1C(CCCCCCC)OCC1

compound40

O1C(CCCCCCCCC)OCC1

compound41

O1C(CCCCCCCCCCC)OCC1

compound42

O1C(CCCCCCC)OC(C)C1

compound43

O1C(CCCCCCCCC)OC(C)C1

compound44

O1C(CCCCCCCCCCC)OC(C)C1

compound45

O1C(C)(CCCCCCC)OCC1

compound46

O1C(C)(CCCCCCCCC)OCC1

compound47

O1C(C)(CCCCCCCCCCC)OCC1

compound48

O1C(C)(CCCCCCC)OC(C)C1

compound49

O1C(C)(CCCCCCCCC)OC(C)C1

compound50

O1C(C)(CCCCCCCCCCC)OC(C)C1

compound26
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compound51

O=C(NCCCCCCCCCCCC)N

compound52

O=C(NCCCCCCCCCCCC)NC

compound53

S=C(NCCCCCCCCCCCC)NC

compound54

O=C(NCCCCCCCCCCCC)NCCCCCCCCCCCC

compound55

S=C(NCCCCCCCCCCCC)NCCCCCCCCCCCC

compound56

O=C(NCCCCCCCCCCCC)Nc1=cc=cc=c1

compound57

S=C(NCCCCCCCCCCCC)Nc1=cc=cc=c1

compound58

C(C(=CCO)C)CC=C(C)C

compound59

N(CCCCCCCCCCCC)CCCCCCCCCCCC

compound60

NCCCCCCCCCCCC

compound61

NCCCCCCCCCCCCCCCCCC

APPENDIX B
A DATABASE OF 777 DESCRIPTORS

The molecular structures of the sixty-one CPEs are transformed into 777 molecular
descriptors. Part of the molecular descriptor names with descriptor codes is listed.
For the full database, consult Mold2_SoftwareIntroduction_12012008.doc at
http://www.fda.gov/downloads/ScienceResearch/BioinformaticsTools/Mold2/UCM1619
40.pdf [68].
Description Code
D001
D002
D003
D004
D005
D006
D007
D008
D009
D010
D011
D012
D013
D014
D015
D016
D017
D018
D019
D020

Descriptor Name
Number of 6-membered aromatic rings only carbon atoms
Number of 03-membered rings
Number of 04-membered rings
Number of 05-membered rings
Number of 06-membered rings
Number of 07-membered rings
Number of 08-membered rings
Number of 09-membered rings
Number of 10-membered rings
Number of 11-membered rings
Number of 12-membered rings
Number of multiple bonds
Number of circuits structure
Number of rotatable bonds
Rotatable bond fraction
Number of double bonds
Number of aromatic bonds
Sum of conventional bond orders (h-depleted)
Number of hydrogen
Number of helium
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